Familial Hypercholesterolaemia: Implementing a systems approach to detection and management – Public Health England

This guide provides further information on the recently updated NICE Guideline (CG71) Familial Hypercholesterolaemia: identification and management. It includes: a summary of recommendations from the recent update of the document an outline of national and European policy documents best practice case

Remote ECG interpretation consultancy services for cardiovascular disease: Medtech innovation briefing [MIB152] – NICE

The technologies described in this briefing are remote electrocardiogram (ECG) interpretation consultancy services. They are used for assisting in diagnosing and decision-making for people with cardiovascular disease. The innovative aspects are that with remote ECG interpretation, a person does not need to travel

Mechanical thrombectomy devices for acute ischaemic stroke: Medtech innovation briefing [MIB153] – NICE

Thetechnologies described in this briefing are 21 mechanical thrombectomy devices of 2 types: stent retrievers and aspiration catheters. They are used to remove blood clots from a main cerebral artery to restore blood flow after acute ischaemic stroke. The innovative aspects are that

Dupilumab for treating moderate to severe atopic dermatitis: Technology appraisal guidance [TA534] – NICE

Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults. Dupilumab is recommended as an option for treating moderate to severe atopic dermatitis in adults, only if: the disease has not responded to at least 1 other

Endometriosis: Quality standard [QS172] – NICE

This quality standard covers diagnosing and managing endometriosis in women, including young women aged 17 and under. It describes high-quality care in priority areas for improvement.

Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs: Technology appraisal guidance [TA537] – NICE

Evidence-based recommendations on ixekizumab (Taltz) for treating active psoriatic arthritis in adults. Ixekizumab alone, or with methotrexate, is recommended as an option for treating active psoriatic arthritis in adults, only if: it is used as described in NICE’s technology appraisal

Alectinib for untreated ALK-positive advanced non-small-cell lung cancer: Technology appraisal guidance [TA536] – NICE

Evidence-based recommendations on alectinib (Alecensa) for untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer in adults. Alectinib is recommended, within its marketing authorisation, as an option for untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer (NSCLC) in adults.

Intermediate care including reablement: Quality standard [QS173] – NICE

This quality standard covers referral and assessment for intermediate care and how to deliver the service. It covers bed-based intermediate care, crisis response, home-based intermediate care and reablement. It describes high-quality care in priority areas for improvement. It does not

Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine: Technology appraisal guidance [TA535] – NICE

Evidence-based recommendations on lenvatinib (Lenvima) and sorafenib (Nexavar) for progressive, locally advanced or metastatic differentiated thyroid cancer in adults who have had radioactive iodine. Lenvatinib and sorafenib are recommended as options for treating progressive, locally advanced or metastatic differentiated thyroid

Varicella: Notifiable in Scotland and Northern Ireland (Green Book Chapter 34) – Public Health England

Varicella immunisation information for public health professionals, including updates.  Varicella zoster Immunoglobulin (VZIG) is a scarce blood product that is offered to individuals at high risk of severe chickenpox following an exposure. This includes immunosuppressed individuals, young babies in their first

Guidance for the development, production and review of information to support UK population screening programmes – UK National Screening Committee

Best practice in terms of developing public information resources such as leaflets to support the national screening programmes. It also provides a definition of ‘personal informed choice’. Information about national screening programmes is available for England, Scotland, Wales and Northern

Acetylene: health effects, incident management and toxicology – Public Health England

Updated information on acetylene (also known as ethyne) for use in responding to chemical incidents. The documents provide information on the health effects of exposure, the chemical’s toxicity and material for responding to a chemical incident.

Working Together to Safeguard Children: A guide to inter-agency working to safeguard and promote the welfare of children – HM Government

This 2018 version replaces the 2015 version. The transitional guidance helps explain how to move to the newrrangements. The statutory framework sets out the legislation relevant to safeguarding and it should be read alongside the statutory guidance. Statutory guidance is

EU Cross-Border Healthcare Directive: How the Directive affects your NHS trust: How to manage payment pathways for visiting European patients – Department of Health and Social Care

Sets out the background of the directive and how it relates to providers when managing visiting European patients who are resident outside the UK but seeking NHS healthcare here.

Overseas chargeable patients, NHS debt and immigration rules: guidance on administration and data sharing – Department of Health and Social Care

Supports NHS organisations on overseas chargeable patients, NHS debt, and immigration rules, including guidance on administration and data sharing. This manual of guidance supersedes all previous guidance on the administration and data sharing of NHS debt.

Operational overview for organisations newly within scope of the NHS Charges to Overseas Visitors Regulations – Department of Health and Social Care

Operational overview for non-NHS organisations within the scope of the NHS charges to overseas visitors regulations.  This document provides help and advice on the implementation of the National Health Service (Charges to Overseas Visitors) Regulations 2015, which have been amended

Guidance on implementing the overseas visitor charging regulations – Department of Health and Social Care

Information for NHS bodies who need to make and recover hospital charges from overseas visitors. This document provides help and advice on the implementation of the National Health Service (Charges to Overseas Visitors) Regulations 2015, which have been amended most

Flu vaccination programme delivery guidance 2018-19 – NHS England

This document sets out some key information to help general practices and pharmacies to plan for the 2018-19 flu vaccination season, and in particular to answer patient queries about the adjuvanted trivalent flu vaccine (aTIV).